Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 1
1994 2
1995 1
1996 1
1997 3
1998 3
1999 2
2000 1
2001 1
2003 1
2008 1
2009 1
2010 1
2012 2
2014 2
2015 2
2016 1
2017 1
2018 1
2019 2
2020 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity.
Haines BB, Denslow A, Grzesik P, Lee JS, Farkaly T, Hewett J, Wambua D, Kong L, Behera P, Jacques J, Goshert C, Ball M, Colthart A, Finer MH, Hayes MW, Feau S, Kennedy EM, Lerner L, Quéva C. Haines BB, et al. Among authors: queva c. Cancer Immunol Res. 2021 Mar;9(3):291-308. doi: 10.1158/2326-6066.CIR-20-0609. Epub 2020 Dec 22. Cancer Immunol Res. 2021. PMID: 33355229
Oncolytic HSV Vectors and Anti-Tumor Immunity.
Glorioso JC, Cohen JB, Goins WF, Hall B, Jackson JW, Kohanbash G, Amankulor N, Kaur B, Caligiuri MA, Chiocca EA, Holland EC, Quéva C. Glorioso JC, et al. Among authors: queva c. Curr Issues Mol Biol. 2021;41:381-468. doi: 10.21775/cimb.041.381. Epub 2020 Sep 17. Curr Issues Mol Biol. 2021. PMID: 32938804 Free article.
Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma.
Wirsching HG, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino PJ, Amankulor N, Campbell JS, McFerrin L, Pattwell SS, Ene C, Hicks A, Ball M, Yan J, Zhang J, Kumasaka D, Pierce RH, Weller M, Finer M, Quéva C, Glorioso JC, Houghton AM, Holland EC. Wirsching HG, et al. Among authors: queva c. JCI Insight. 2019 Jul 11;4(13):e128217. doi: 10.1172/jci.insight.128217. eCollection 2019 Jul 11. JCI Insight. 2019. PMID: 31292299 Free PMC article.
Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability.
Kennedy EM, Farkaly T, Grzesik P, Lee J, Denslow A, Hewett J, Bryant J, Behara P, Goshert C, Wambua D, De Almeida A, Jacques J, Deavall D, Rottman JB, Glorioso JC, Finer MH, Haines BB, Quéva C, Lerner L. Kennedy EM, et al. Among authors: queva c. Mol Ther Oncolytics. 2020 Aug 8;18:476-490. doi: 10.1016/j.omto.2020.08.004. eCollection 2020 Sep 25. Mol Ther Oncolytics. 2020. PMID: 32953982 Free PMC article.
Peptibodies: A flexible alternative format to antibodies.
Shimamoto G, Gegg C, Boone T, Quéva C. Shimamoto G, et al. Among authors: queva c. MAbs. 2012 Sep-Oct;4(5):586-91. doi: 10.4161/mabs.21024. Epub 2012 Jul 23. MAbs. 2012. PMID: 22820181 Free PMC article. Review.
A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia.
Primo D, Scarfò L, Xochelli A, Mattsson M, Ranghetti P, Espinosa AB, Robles A, Gorrochategui J, Martínez-López J, de la Serna J, González M, Gil AC, Anguita E, Iraheta S, Munugalavadla V, Quéva C, Tannheimer S, Rosenquist R, Stamatopoulos K, Ballesteros J, Ghia P. Primo D, et al. Among authors: queva c. Oncotarget. 2018 May 25;9(40):26019-26031. doi: 10.18632/oncotarget.25419. eCollection 2018 May 25. Oncotarget. 2018. PMID: 29899839 Free PMC article.
The Mad protein family links transcriptional repression to cell differentiation.
McArthur GA, Laherty CD, Quéva C, Hurlin PJ, Loo L, James L, Grandori C, Gallant P, Shiio Y, Hokanson WC, Bush AC, Cheng PF, Lawrence QA, Pulverer B, Koskinen PJ, Foley KP, Ayer DE, Eisenman RN. McArthur GA, et al. Among authors: queva c. Cold Spring Harb Symp Quant Biol. 1998;63:423-33. doi: 10.1101/sqb.1998.63.423. Cold Spring Harb Symp Quant Biol. 1998. PMID: 10384307 Review. No abstract available.
33 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page